Talk to Alison
00 1 718 618 48 97
Search inside this page
Top countries
Publication dates
Publishers
All regions
data types
Free Market Research Guides to Download
» Purchase Premium Reports
121-160 of about 4 800 reports
This report provides data on the therapeutic development for Cystic Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides data on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
This report provides data on the therapeutic development for Pruritus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...
This report provides data on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides data on the therapeutic development for Sickle Cell Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
This report provides data on the therapeutic development for Bile Duct Cancer (Cholangiocarcinoma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
This report provides data on the therapeutic development for Polycystic Kidney Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
This report provides data on the therapeutic development for Bronchiectasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides data on the therapeutic development for Schizophrenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Perennial Allergic Rhinitis - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Perennial Allergic Rhinitis - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
Other Hematological Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Other Hematological Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
This report provides data on the therapeutic development for Non-Hodgkin Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
This report provides data on the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Lung Disease - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Lung Disease - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
This report provides data on the therapeutic development for Traumatic Brain Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013', provides an overview of the indication's ...
Athlete's Foot (Tinea Pedis) ? Pipeline Review, H1 2012 What's inside this report? Global Industries Direct's, 'Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2012', provides an overview of the ...
Cardiomyopathy - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Cardiomyopathy - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...
This report provides data on the therapeutic development for Burkitt Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
This report provides information on the therapeutic development for Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013', provides an overview of the indication's ...
This report provides data on the therapeutic development for Friedreich Ataxia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2013', provides an overview of the ...
Secondary Hyperparathyroidism - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Secondary Hyperparathyroidism - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...
This report provides information on the therapeutic development for Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013', provides an overview of the ...
This report provides data on the therapeutic development for Inflammatory Bowel Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
This report provides data on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with latest updates, and special features on late-stage and discontinued projects. ...
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2013', provides an overview of the ...
This report provides data on the therapeutic development for Squamous Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
» Download Public Reports
About 17 000 reports
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
» Read our Company Profiles
About 200 CompaniesReportlinker.com © Copyright 2013. All rights reserved.